Clearside Biomedical, Inc. (CLSD) Operating Lease, Right-of-Use Asset USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Clearside Biomedical, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2019 to 2024.
  • Clearside Biomedical, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $803 K, a 24% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $803 K -$254 K -24% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $869 K -$248 K -22.2% Dec 31, 2023 10-Q 2024-05-10
Q3 2023 $933 K +$707 K +313% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $996 K +$720 K +261% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.06 M +$733 K +226% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.12 M +$748 K +203% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $226 K -$186 K -45.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $276 K -$176 K -38.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $324 K -$167 K -34% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $369 K -$159 K -30.1% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $412 K -$151 K -26.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $452 K -$143 K -24% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $491 K -$136 K -21.7% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $528 K -$128 K -19.5% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $563 K -$243 K -30.1% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $595 K -$272 K -31.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $627 K -$298 K -32.2% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $656 K Dec 31, 2019 10-K 2021-03-15
Q3 2019 $806 K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $867 K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $925 K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.